hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223
Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-22...
Saved in:
Published in | American journal of physiology: Gastrointestinal and liver physiology Vol. 319; no. 6; pp. G703 - G717 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment.
Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition.
NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment. |
---|---|
AbstractList | Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition.
Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment. Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition. Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition.NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment.Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition.NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment. Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment. Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition. NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment. |
Author | Zhuang, Yuan Du, Lei Tan, Peng Zhang, Xiutian |
Author_xml | – sequence: 1 givenname: Xiutian surname: Zhang fullname: Zhang, Xiutian organization: Department of Gastroenterology, Linyi People's Hospital, Linyi, China – sequence: 2 givenname: Peng surname: Tan fullname: Tan, Peng organization: Internal Medicine Teaching and Research Section, Shandong Medical College, Linyi, China – sequence: 3 givenname: Yuan surname: Zhuang fullname: Zhuang, Yuan organization: Histology and Embryology Teaching and Research Section, Shandong Medical College, Linyi, China – sequence: 4 givenname: Lei surname: Du fullname: Du, Lei organization: Department of Oncology, Linyi People's Hospital, Linyi, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32878470$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtr3DAUhUVISSZp9lkFQTZd1FO9bEvLYegLhhb6WAtZlp072JIj2aH9J_251UySLgJdCF0O3706uucCnfrgHULXlKwpLdk7s596WBNCqVwzwsgJWmWZFbQU9SlaEap4QWVZn6OLlPaEkJJReobOOZO1FDVZoT93yWgL0X77stF5UClrvEzR9ctgZpfw991WbAR2v7KWEgSP54DB30EDMx6hj2bO4tssPZh0rIxv8-kh9M67BAmHDk_G2-gyarHNpYvYumFI-AEMbsC34PvD3BFsDNlIwRh_jV51Zkju6um-RD8_vP-x_VTsvn78vN3sCssVnwslHKFWdRVXZde6hnSis5Rb1jDDqJSl4TWvKuWotFxKo1TbGF51grNKlIbyS_Tmce4Uw_3i0qxHSAd3xruwJM0EV6pWSpCM3r5A92GJPrvLVKWkyO_xTN08UUszulZPEUYTf-vnnWeAPAL5sylF1_1DKNGHWPUxVn2MVR9izS3VixYL83HzczQw_L_xL7adpr4 |
CitedBy_id | crossref_primary_10_3390_cancers13164161 crossref_primary_10_1186_s12935_021_02392_y crossref_primary_10_1016_j_drudis_2022_05_012 crossref_primary_10_1002_cbin_12049 crossref_primary_10_1016_j_critrevonc_2024_104612 crossref_primary_10_1002_jbt_23274 crossref_primary_10_1186_s13046_023_02894_9 crossref_primary_10_3390_jpm11020127 crossref_primary_10_1002_cam4_5499 crossref_primary_10_1016_j_pharmthera_2021_107869 crossref_primary_10_18632_aging_203740 crossref_primary_10_1038_s41598_022_13212_2 crossref_primary_10_1007_s10585_022_10197_0 crossref_primary_10_3389_fcell_2022_1023332 crossref_primary_10_1038_s41598_023_28439_w crossref_primary_10_1186_s13765_022_00716_8 crossref_primary_10_1007_s11033_022_07723_4 crossref_primary_10_1007_s12094_021_02599_5 crossref_primary_10_1007_s12094_023_03178_6 crossref_primary_10_1080_08820139_2021_2001496 crossref_primary_10_3390_cancers14246187 crossref_primary_10_1016_j_semcancer_2020_12_026 crossref_primary_10_1007_s12672_024_01488_x crossref_primary_10_1038_s43018_022_00470_2 crossref_primary_10_1007_s00424_024_02937_w crossref_primary_10_1016_j_ncrna_2023_12_002 crossref_primary_10_2147_CMAR_S308809 crossref_primary_10_1097_JP9_0000000000000087 crossref_primary_10_1186_s13578_022_00833_3 crossref_primary_10_3390_cancers12113250 crossref_primary_10_1002_ctm2_356 crossref_primary_10_1080_08916934_2021_1963958 crossref_primary_10_3390_ijms25158191 crossref_primary_10_1038_s41598_022_23764_y crossref_primary_10_1016_j_omton_2024_200919 crossref_primary_10_3390_biom14010060 crossref_primary_10_1007_s12033_023_00874_0 crossref_primary_10_1002_jcla_24247 crossref_primary_10_1016_j_prp_2022_153833 crossref_primary_10_1016_j_canlet_2024_217070 crossref_primary_10_3390_ijms242015166 crossref_primary_10_3389_fmolb_2022_893846 |
Cites_doi | 10.1371/journal.pone.0164150 10.1016/j.bbrc.2018.06.089 10.1136/bmj.e2476 10.1038/s41571-018-0112-1 10.1053/j.gastro.2016.09.060 10.1038/cddis.2017.556 10.1016/j.ymthe.2019.05.011 10.1007/s10456-017-9556-7 10.26355/eurrev_201909_19000 10.1159/000375164 10.3892/mmr.2018.8827 10.3390/ijms20020296 10.2217/fon-2016-0010 10.3748/wjg.v22.i44.9694 10.1038/s41576-019-0158-7 10.7754/Clin.Lab.2017.170731 10.1002/iub.1315 10.3748/wjg.v23.i47.8345 10.7717/peerj.7968 10.1080/15384047.2019.1617563 10.1186/s13046-019-1041-2 10.1016/S0140-6736(16)00141-0 10.1016/j.molcel.2016.09.027 10.3727/096504016X14685034103437 10.1016/j.canlet.2015.06.003 10.15252/embj.2018100836 10.1038/bjc.2016.451 10.3233/CBM-181877 10.1186/s12943-015-0327-z 10.1016/j.biopha.2018.10.177 10.1136/jmedgenet-2016-103758 10.2147/OTT.S150678 10.1016/j.canlet.2019.02.051 10.1042/CS20190286 10.1016/j.bbrc.2018.09.073 10.1001/jama.2013.284664 10.18632/aging.101763 10.1155/2020/1204605 10.1155/2019/7630894 10.1097/CM9.0000000000000465 |
ContentType | Journal Article |
Copyright | Copyright American Physiological Society Dec 2020 |
Copyright_xml | – notice: Copyright American Physiological Society Dec 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1152/ajpgi.00118.2020 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1547 |
EndPage | G717 |
ExternalDocumentID | 32878470 10_1152_ajpgi_00118_2020 |
Genre | Journal Article |
GroupedDBID | --- 23M 2WC 39C 4.4 5GY 5VS 6J9 AAFWJ AAYXX ABJNI ACPRK ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BKOMP CITATION E3Z EBS EMOBN F5P GX1 H13 ITBOX KQ8 OK1 P2P PQQKQ RAP RHI RPL RPRKH TR2 W8F WOQ XSW YSK CGR CUY CVF DIK ECM EIF NPM RHF K9. 7X8 |
ID | FETCH-LOGICAL-c393t-94e01c9f6395fdeb0f4fc13c2b2a21885a373669e18c388a99dba36f432645a13 |
ISSN | 0193-1857 1522-1547 |
IngestDate | Fri Jul 11 03:21:49 EDT 2025 Mon Jun 30 07:52:23 EDT 2025 Thu Jan 02 22:57:39 EST 2025 Tue Jul 01 03:43:04 EDT 2025 Thu Apr 24 23:02:34 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | microRNA-223 pancreatic cancer invasion angiogenesis migration solute carrier family 4 member 4 hsa_circular RNA 001587 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c393t-94e01c9f6395fdeb0f4fc13c2b2a21885a373669e18c388a99dba36f432645a13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 32878470 |
PQID | 2469841883 |
PQPubID | 48585 |
ParticipantIDs | proquest_miscellaneous_2439979940 proquest_journals_2469841883 pubmed_primary_32878470 crossref_primary_10_1152_ajpgi_00118_2020 crossref_citationtrail_10_1152_ajpgi_00118_2020 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-12-01 20201201 |
PublicationDateYYYYMMDD | 2020-12-01 |
PublicationDate_xml | – month: 12 year: 2020 text: 2020-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda |
PublicationTitle | American journal of physiology: Gastrointestinal and liver physiology |
PublicationTitleAlternate | Am J Physiol Gastrointest Liver Physiol |
PublicationYear | 2020 |
Publisher | American Physiological Society |
Publisher_xml | – name: American Physiological Society |
References | B20 B42 B21 B22 B23 Chien YC (B9) 2018; 8 B24 Pishvaian MJ (B30) 2017; 31 B25 B26 B27 B28 B29 B31 B10 B32 B11 B33 B12 B34 B13 B35 B14 B36 B15 B37 B16 B38 B17 B39 B18 B19 B1 B2 B3 B4 B5 B6 B7 B8 B40 B41 |
References_xml | – ident: B29 doi: 10.1371/journal.pone.0164150 – ident: B41 doi: 10.1016/j.bbrc.2018.06.089 – ident: B6 doi: 10.1136/bmj.e2476 – ident: B35 doi: 10.1038/s41571-018-0112-1 – ident: B16 doi: 10.1053/j.gastro.2016.09.060 – ident: B34 doi: 10.1038/cddis.2017.556 – ident: B32 doi: 10.1016/j.ymthe.2019.05.011 – ident: B1 doi: 10.1007/s10456-017-9556-7 – ident: B15 doi: 10.26355/eurrev_201909_19000 – ident: B13 doi: 10.1159/000375164 – volume: 8 start-page: 422 year: 2018 ident: B9 publication-title: Am J Cancer Res – ident: B12 doi: 10.3892/mmr.2018.8827 – ident: B27 doi: 10.3390/ijms20020296 – ident: B3 doi: 10.2217/fon-2016-0010 – ident: B17 doi: 10.3748/wjg.v22.i44.9694 – ident: B21 doi: 10.1038/s41576-019-0158-7 – volume: 31 start-page: 159 year: 2017 ident: B30 publication-title: Oncology (Williston Park) – ident: B25 doi: 10.7754/Clin.Lab.2017.170731 – ident: B2 doi: 10.1002/iub.1315 – ident: B39 doi: 10.3748/wjg.v23.i47.8345 – ident: B26 doi: 10.7717/peerj.7968 – ident: B36 doi: 10.1080/15384047.2019.1617563 – ident: B38 doi: 10.1186/s13046-019-1041-2 – ident: B20 doi: 10.1016/S0140-6736(16)00141-0 – ident: B10 doi: 10.1016/j.molcel.2016.09.027 – ident: B14 doi: 10.3727/096504016X14685034103437 – ident: B31 doi: 10.1016/j.canlet.2015.06.003 – ident: B28 doi: 10.15252/embj.2018100836 – ident: B23 doi: 10.1038/bjc.2016.451 – ident: B19 doi: 10.3233/CBM-181877 – ident: B24 doi: 10.1186/s12943-015-0327-z – ident: B4 doi: 10.1016/j.biopha.2018.10.177 – ident: B8 doi: 10.1136/jmedgenet-2016-103758 – ident: B7 doi: 10.2147/OTT.S150678 – ident: B18 doi: 10.1016/j.canlet.2019.02.051 – ident: B11 doi: 10.1042/CS20190286 – ident: B5 doi: 10.1016/j.bbrc.2018.09.073 – ident: B33 doi: 10.1001/jama.2013.284664 – ident: B37 doi: 10.18632/aging.101763 – ident: B42 doi: 10.1155/2020/1204605 – ident: B40 doi: 10.1155/2019/7630894 – ident: B22 doi: 10.1097/CM9.0000000000000465 |
SSID | ssj0005211 |
Score | 2.5589895 |
Snippet | Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic... Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | G703 |
SubjectTerms | Adult Aged Angiogenesis Animals Argonaute 2 protein Cell adhesion & migration Cell Line, Tumor Cell migration Cell Movement - genetics Cell proliferation Circular RNA Female Humans Immunoprecipitation Male Matrix metalloproteinase Matrix Metalloproteinase 2 - metabolism Matrix Metalloproteinase 9 - metabolism Metalloproteinase Mice Mice, Inbred BALB C Mice, Nude MicroRNAs MicroRNAs - genetics MicroRNAs - metabolism Middle Aged miRNA Neoplasm Invasiveness - genetics Neovascularization, Pathologic - genetics Pancreatic cancer Pancreatic Neoplasms - genetics Pancreatic Neoplasms - pathology Pheochromocytoma cells Reporter gene RNA, Circular - genetics Sodium-Bicarbonate Symporters - biosynthesis Sodium-Bicarbonate Symporters - genetics Transfection Tumorigenesis Up-Regulation - genetics Vascular endothelial growth factor Xenograft Model Antitumor Assays Xenografts |
Title | hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32878470 https://www.proquest.com/docview/2469841883 https://www.proquest.com/docview/2439979940 |
Volume | 319 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKkKa9INiAFQYyEkJCWVhqO038WA3YxJ9pQCeVp8pxnc5oTao2mQSfhE_E5-JsJ2mgGwJeoii-Omnul_Pd-eczQk9TEdJA8tCnQcp9JiPlJ3EkAcuExGoyMdUBDNvipH98xt6MwlGn86PFWiqL5IX8duW6kv_RKlwDvZpVsv-g2aZTuADnoF84gobh-Fc6Pl-KsdQL-fFkYFhjYRx55XzhdpdXS-_Tu0M2YKaIvyO7ZsbR1Nm5TnThzfTUKd-8ZJ1dimV17qq3TnU-NWbQlSsBk-G8S2lYYlItPJPwX3qXWniJdgtjoO-ZYffBw_jEre5tytvW00KtOhU2peKWytCBdySWxSI3tSvA5GRV_YILwxlpCa4luUe6LFrwHrpk7qmqRmMrWlayn8uV4MvSpiOUbuc8SJs_oio7DTE0eH9R25DTyvjqNbN8FNlCCleMF6GpPyu-zKfazkkZsp9dnFe04DOfWfxQCC5hLA9WI2fDZ6ybbqCbBMIVs5PG2w9xi2rU69VT5CE5-P12W2iz7uBX7-iakMe6PsPb6FYVs-CBA-Ad1FHZNtoZZKLIZ1_xM3zaaGgbbb6vyBo76Ps6PHELntjBE6_giYscV_DEDTz3cQ3OfQygwG1o4jzFK2hiB01soYkBmriCpum3Dc276Oz1q-HhsV9tBOJLymnhc6aCnuQpeNNhOlFJkLJU9qgkCRHgosahoBHt97nqxZLGseB8kgjaTxnEJiwUPXoPbWR5pnYRZlzFIQkmEDdwFrNA9NMEQog-AbeX8CToooNaAfCGHBvGbNZyMbbRckjGVnuWChqPjfa66Hnzi7mrEPMH2b1ap-Pqi1uOidnElcHfoF30pGkGK29el8hUXhoZCCQizhl0cd9hoblZjZ0H17Y8RFurr2gPbRSLUj0CX7pIHlug_gQ7zcno |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=hsa_circRNA_001587+upregulates+SLC4A4+expression+to+inhibit+migration%2C+invasion%2C+and+angiogenesis+of+pancreatic+cancer+cells+via+binding+to+microRNA-223&rft.jtitle=American+journal+of+physiology%3A+Gastrointestinal+and+liver+physiology&rft.au=Zhang%2C+Xiutian&rft.au=Tan%2C+Peng&rft.au=Zhuang%2C+Yuan&rft.au=Du%2C+Lei&rft.date=2020-12-01&rft.eissn=1522-1547&rft.volume=319&rft.issue=6&rft.spage=G703&rft_id=info:doi/10.1152%2Fajpgi.00118.2020&rft_id=info%3Apmid%2F32878470&rft.externalDocID=32878470 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0193-1857&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0193-1857&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0193-1857&client=summon |